C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2009
12/08/2009	US7629295 Determination of a specific immunoglobulin using multiple antigens
12/08/2009	US7629171 Genetically altered hybridomas, myelomas and B cells that facilitate the rapid production of monoclonal antibodies
12/08/2009	US7629168 Reversibly immortalized human pancreatic islet cell line containing an hTERT gene and an SV40T gene each interposed between a pair of LoxP sequences, characterized in that it is capable of producing insulin and enhancing expression of insulin after excising the hTERT gene and the SV40T gene, NAKT-13
12/08/2009	US7629163 Methods for producing modified glycoproteins
12/08/2009	US7629160 Relating to the expression of vankyrin proteins in cell lines to increase their viability, longevity and capacity for protein production; vankyrin gene family comprises 7 genes on CsIV genome segments P and I2
12/08/2009	US7629149 Polynucleotide encoding an IL-28A polypepide
12/08/2009	US7629148 Polynucleotide encoding an IL-28B polypeptide
12/08/2009	US7629146 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent; inhibits the migration of cultured cells as well as inhibiting angiogenesis, tumor growth, or any other processes that involve the migration of cells in vivo
12/08/2009	US7629145 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders
12/08/2009	US7629144 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides
12/08/2009	US7629138 Estrogen receptor genes and utilization thereof
12/08/2009	US7629135 Toll-like receptor agonists and antagonists and methods of use thereof
12/08/2009	US7629132 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, apoptosis and autoimmune diseases
12/08/2009	US7628994 S. epidermidis antigens
12/08/2009	US7628987 Vectors derived from antibodies for transferring substances into cells
12/08/2009	US7628986 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
12/08/2009	US7628983 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide
12/08/2009	CA2510797C Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/08/2009	CA2268143C Production of a multimeric protein by cell fusion method
12/08/2009	CA2202016C Process for the production of lipstatin and of tetrahydrolipstatin
12/08/2009	CA2163012C Anti-egfr single-chain fvs and anti-egfr antibodies
12/06/2009	CA2665955A1 Helicobacter species and cultivation thereof
12/03/2009	WO2009146362A1 Yeast strain for the production of proteins with terminal alpha-1,3-linked galactose
12/03/2009	WO2009145180A1 Novel selection marker gene and use thereof
12/03/2009	WO2009144739A1 Amorphous daptomycin and a method of purification thereof
12/03/2009	WO2009144245A1 Method for increasing growth rate
12/03/2009	WO2009144161A1 Microorganism optimized for secretion
12/03/2009	WO2009125343A3 Method for producing selenoproteins
12/03/2009	WO2009091994A9 Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
12/03/2009	WO2008093165A3 The use of pgil ohgosaccharyltransferase for o-glycosylating proteins
12/03/2009	US20090300801 Isolated menthone reductase and nucleic acid molecules encoding same
12/03/2009	US20090300799 Plant galactinol synthase homologs
12/03/2009	US20090300794 Manipulation Of The Nitrogen Metabolism
12/03/2009	US20090300778 Neutral Sphingomyelinase-E and Its Use
12/03/2009	US20090299763 Methods of cell-based technologies
12/03/2009	US20090299039 Anti-a33 antibody
12/03/2009	US20090298762 Conjugates of biologically active proteins having a modified in vivo half-life
12/03/2009	US20090298760 Modified Coagulation Factor VIIa With Extended Half-Life
12/03/2009	US20090298754 Hai-1 and hai-2 in cancer therapy
12/03/2009	US20090298126 Methods of increasing secretion of polypeptides having biological activity
12/03/2009	US20090298125 Halohydrin dehalogenases and related polynucleotides
12/03/2009	US20090298124 Site-specific incorporation of redox active amino acids into proteins
12/03/2009	US20090298123 Novel Lipase Genes
12/03/2009	US20090298122 Translational Elongation Factor Promoter From Pichia Pastoris And Method For Producing Recombinant Protein Using The Same
12/03/2009	US20090298121 Expression of soluble therapeutic proteins
12/03/2009	US20090298120 Method for expressing sialylated glycoproteins in mammalian cells and cells thereof
12/03/2009	US20090298119 Genetically encoded coumarin amino acids
12/03/2009	US20090298118 Enzymatic Conversion of Oligopeptide Amides to Oligopeptide Alkylesters
12/03/2009	US20090298108 Method for Identifying PDE11 Modulators
12/03/2009	US20090298105 Reconstituted histone methyltransferase complex and methods of identifyi ng modulators thereof
12/03/2009	US20090298098 N1, n12-diacetylspermine as tumor marker
12/03/2009	US20090298055 Production of proteins
12/03/2009	US20090297689 Peptidylarginine deiminase and uses thereof in the production of citrullinated proteins and peptides
12/03/2009	US20090297550 Chloroplast-derived human vaccine antigens against malaria
12/03/2009	US20090297535 Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling
12/03/2009	US20090297531 Compositions and methods for the diagnosis and treatment of tumor
12/03/2009	US20090297529 Anti-flt3 antibodies
12/03/2009	US20090297527 Binding Domains of Proteins of the Repulsive Guidance Molecule (RGM) Protein Family and Functional Fragments Thereof, and Their Use
12/03/2009	US20090297526 Membranolytic Polypeptides and Methods of Use
12/03/2009	US20090297522 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
12/03/2009	US20090297514 Humanization of antibodies
12/03/2009	US20090297511 Prevention and treatment of amyloidogenic disease
12/03/2009	US20090297504 Bcma polypeptides and uses thereof
12/03/2009	US20090297496 Lysosomal Acid Lipase Therapy for NAFLD and Related Diseases
12/03/2009	US20090297495 Hydrolases, nucleic acids encoding them and methods for improving paper strength
12/03/2009	US20090297482 Probiotic strain and antimicrobial peptide derived therefrom
12/03/2009	US20090294288 High-sensitivity proteolysis assay
12/03/2009	CA2725947A1 Yeast strain for the production of proteins with terminal alpha-1,3-linked galactose
12/03/2009	CA2725674A1 Novel selection marker gene and use thereof
12/02/2009	EP2128260A2 Modified TGF-beta superfamily proteins
12/02/2009	EP2128252A1 Fused protein containing insulin precursor of overexpression and secretion type, dna encoding the same and method of producing insulin
12/02/2009	EP2128249A1 Zinc oxide-binding antibody and use thereof
12/02/2009	EP2128246A1 Methods and composition for the production of orthoganal tRNA-Aminoacyl-tRNA synthetase pairs
12/02/2009	EP2126106A1 Process for producing and purifying factor viii and its derivatives
12/02/2009	EP2126055A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
12/02/2009	EP2125006A2 Synthetic mini/micro-dystrophin genes to restore nnos to the sarcolemma
12/02/2009	EP2124548A2 Disintegrin variants and pharmaceutical uses thereof
12/02/2009	EP1684801B1 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens
12/02/2009	EP1555324B1 Defructosylation method
12/02/2009	EP1248804B2 Recombinant antibodies to human interleukin-1 beta
12/02/2009	CN101595228A Multiple gene expression including SORF constructs and methods with polyproteins, pro-proteins, and proteolysis
12/02/2009	CN101595132A Use of thermostable biotin-binding protein and solid support having the protein bound thereto
12/02/2009	CN101591692A Method for producing active small peptide of duck hemocyte
12/02/2009	CN101591691A High density fermentation culture medium of restructured human interferon alpha2b
12/02/2009	CN101591690A High density fermentation method of restructured human interferon alpha2b
12/02/2009	CN101591674A Method for producing American cockroach allergen protein Pera 9 in baculovirus-insect expression system
12/02/2009	CN101591668A Method for producing Buthus martensii Karsch toxin AGAP
12/02/2009	CN101591665A Slpa as a tool for recombinant protein and enzyme technology
12/02/2009	CN101591660A Method for excreting and expressing recombinant human granulocyte-colony factor in colon bacillus
12/02/2009	CN101591635A Recombinant streptomyces ansochromogenes, preparation method thereof and use thereof
12/02/2009	CN101591634A Method for producing nikkomycin Z, special culture medium of nikkomycin Z and special engineering bacteria of nikkomycin Z
12/02/2009	CN101591622A Melittin gene fission yeast engineering bacteria and construction method and application thereof
12/02/2009	CN101591397A Recombinant expression and application of long-acting thymosin alpha1
12/02/2009	CN101591380A Bacterial insecticidal protein
12/02/2009	CN101589728A Protein attractant for Bactrocera dorsalis Hendel and preparation method thereof
12/02/2009	CN100564540C Engineering of leader peptides for the secretion of recombinant proteins in bacteria
12/02/2009	CN100564519C Method for preparing antibiotic peptide and transfer factor by in vitro culture and induction of lymphocyte
12/02/2009	CN100563709C Novel targeted tissue factor antibody as anticoagulants
12/01/2009	US7626013 HIV-1 DNA fragments that hybridize to genomic HIV-1DNA
12/01/2009	US7626012 Nucleic acids encoding monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents

1 ... 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 ... 1125